Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.

PloS one - 1 Jan 2018

Bancone Germana, Gornsawun Gornpan, Chu Cindy S, Porn Pen, Pal Sampa, Bansil Pooja, Domingo Gonzalo J, Nosten Francois

Abstract excerpt

INTRODUCTION: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy in the human population affecting an estimated 8% of the world population, especially those living in areas of past and present malaria endemicity. Decreased G6PD enzymatic activity is associated with drug-induced hemolysis and increased risk of severe neonatal hyperbilirubinemia leading to brain damage. The G6PD gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminoquinolines
Share to Endemic Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucosephosphate Dehydrogenase Deficiency

Share to Malaria, Vivax

Share to Myanmar

Share to Point-of-Care Systems

Share to Pregnancy Complications, Hematologic

Share to Spectrophotometry, Ultraviolet

Source

Open in PubMed Open full text

Identifiers

PMID: 29738562
DOI: 10.1371/journal.pone.0196716
PMCID: PMC5940185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.PMID 29738562Read ↗

Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in MauritaniaSemantic proximity Read ↗

Diagnostic accuracy of the Point-of-Care Standard G6PD test™ (SD Biosensor) for Glucose-6-phosphate dehydrogenase deficiency: a systematic review of the literatureSemantic proximity Read ↗

Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti.Semantic proximity Read ↗

Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.Semantic proximity Read ↗

Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd), CareStart qualitative rapid diagnostic test performance, and genetic variants in two malaria-endemic areas in Sudan.Semantic proximity Read ↗

Assessment of Glucose-6 phosphate dehydrogenase deficiency in malaria suspected patients attending at Shele and Lante Health Center, Southern EthiopiaSemantic proximity Read ↗

Quantitative G6PD point-of-care test can be used reliably on cord blood to identify male and female newborns at increased risk of neonatal hyperbilirubinaemia: a mixed method studySemantic proximity Read ↗

Integrated Phenotypic and Genotypic Approaches for Accurate Diagnosis of G6PD Deficiency: Implications for Drug Safety in ThailandSemantic proximity Read ↗

Prevalence of G6PD deficiency and diagnostic accuracy of a G6PD point-of-care test among a population at risk of malaria in Myanmar.Semantic proximity Read ↗

Evaluation of the phenotypic test and genetic analysis in the detection of glucose-6-phosphate dehydrogenase deficiencySemantic proximity Read ↗

Glucose-6-phosphate dehydrogenase deficiencySemantic proximity Read ↗

Newborn screening of glucose-6-phosphate dehydrogenase deficiency in Guangxi, China: determination of optimal cutoff value to identify heterozygous female neonates.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.